BOCA RATON, Fla., Nov. 01, 2019 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological conditions, announces that management will hold a conference call on Wednesday, November 6, 2019 at 4:30 p.m. Eastern time to discuss the financial results for the third quarter […]
2019 MEDICA Fair
Join Sensus Healthcare at the 2019 MEDICA Fair from November 18-21 in Dusseldorf, Germany. For more information click here.
2019 New Frontiers in Cosmetic Medicine & Medical Dermatology Symposium
Join Sensus Healthcare at the 9th Annual New Frontiers in Cosmetic Medicine & Medical Dermatology Symposium from November 16-17 in Hasbrouck Heights, NJ. For more information click here.
2019 ASDS Annual Meeting
Join Sensus Healthcare at the 2019 ASDS Annual Meeting from October 24-27 in Chicago, IL. For more information click here.
Penn-Ohio AAPM: Novel Technologies in Radiation Physics
Join Sensus Healthcare at Penn-Ohio AAPM: Novel Technologies in Radiation Physics from October 25-26 in Mayfield Village, OH. For more information click here.
SRT is a Great Alternative for Treating Non Melanoma Skin Cancer vs using Mohs Surgery
At Sensus Healthcare, our focus is on excellent patient outcomes. Studies have proven that Superficial Radio Therapy (SRT), is a highly effective treatment for Non-Melanoma Skin Cancer (NMSC) vs using Mohs surgery. NMSC includes Basal Cell Carcinoma and Squamous Cell Carcinoma. These cancers are rarely life-threatening but can cause complications if they are left untreated. […]
Sensus Healthcare Reports Second Quarter 2019 Financial Results
· Resumes double-digit revenue growth, up 23% over the prior year quarter · Affirms expectations for full-year double-digit revenue growth · Conference call begins at 4:30 p.m. Eastern time today BOCA RATON, Fla., Aug. 08, 2019 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments […]
Sensus Healthcare to Host Second Quarter 2019 Financial Results and Business Update Conference Call on August 8, 2019
BOCA RATON, Fla., July 30, 2019 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological conditions, announces that management will hold a conference call on Thursday, August 8, 2019 at 4:30 p.m. Eastern time to discuss the financial results for the second quarter […]
SRT & Keloid Treatment: Tony Perkins Interview
We had the pleasure of inviting patient advocate Tony Perkins to the Sensus Headquarters to tell his story of how utilizing superficial radiation therapy (SRT) as his post-operative keloid treatment help changed his life. Throughout Tony’s lifetime, he received several surgical treatments – none of which seemed to stop the continuous growth of his facial […]
TLC’s Dr. Pimple Popper Treats Keloids with SRT
Dr. Sandra Lee a.k.a Dr. Pimple Popper treats keloids with Sensus Healthcare’s SRT-100™. Thank you, Dr. Lee, for showing what amazing capabilities superficial radiation therapy can have when used on keloids directly after surgical removal! Here are some before and afters of the patient treated by Dr. Sandra Lee. If you did not catch Sensus’ […]
Dr. Pimple Popper from TLC utilizes SRT
Tune in to TLC on Thursday, July 11th at 9 est / 8 central to see Dr. Sandra Lee, otherwise known as “Dr. Pimple Popper” utilize Sensus Healthcare’s Superficial Radio Therapy (SRT) to treat one of her patients after keloid removal! Superficial Radio Therapy is giving countless keloid sufferers new hope and new confidence. The […]
Sensus Healthcare to Present at the Raymond James Inaugural Life Sciences and MedTech Conference
BOCA RATON, Fla., June 10, 2019 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological conditions, announced today that Joe Sardano, CEO of the Company, will present a corporate overview at the Raymond James Inaugural Life Sciences and MedTech Conference on Wednesday, June […]
Sensus Healthcare to Present at the 20th Annual B. Riley FBR Investor Conference
BOCA RATON, Fla., May 15, 2019 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological conditions, announced today that Joe Sardano, CEO of the Company, will present a corporate overview at the 20th Annual B. Riley FBR Investor Conference on Thursday, May 23 […]
Cancer Near Eye Treated by SRT
Dr. Kevin Schewe, radiation oncologist and medical director at Alliance Cancer Care Colorado, utilized Sensus Healthcare’s SRT to treat an elderly patient with stage 1 basal cell carcinoma cancer near the eye. Without the help of the SRT, this would have possibly caused the patient immobility of the eyelid. Check out the amazing results! To […]
NBC 9News Features Sensus Healthcare’s SRT
05/10/2019 Watch as Dr. Kevin Schewe, radiation oncologist and medical director at Alliance Cancer Care Colorado, speaks about Sensus Healthcare’s SRT and the amazing effects it has on treating non-melanoma skin cancer. “There are 5.4 million new basal cell and squamous cell skin cancers per year in the United States, developing in 3.3 million people”, […]
Sensus Healthcare Reports First Quarter 2019 Financial Results
– Premier, Inc. adds SRT to its group purchasing contracts – Ships second Sculptura™ system to Rabin Medical Center in Israel – Reaffirms expectations for double-digit full-year revenue growth – Conference call begins at 4:30 p.m. Eastern time today BOCA RATON, Fla., May 9, 2019 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company […]
Sensus Healthcare Awarded Brachytherapy Products Agreement with Premier
BOCA RATON, Fla., May 8, 2019 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in novel radiation oncology technologies and solutions, has been awarded a group purchasing agreement for Brachytherapy Products with Premier. Effective August 1, 2019, the new agreement allows Premier members, at their discretion, to take advantage of special pricing […]
Sensus Healthcare to Host First Quarter 2019 Financial Results and Business Update Conference Call on May 9, 2019
BOCA RATON, Fla., April 25, 2019 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological conditions, announces that management will hold a conference call on Thursday, May 9, 2019 at 4:30 p.m. Eastern time to discuss the financial results for the first quarter […]
Sensus Healthcare Signs R&D Agreement to Collaborate with Perelman School of Medicine at the University of Pennsylvania on World’s First Sculptura™ Intraoperative Radiotherapy System
Sculptura™ Provides Single Treatment During Surgery for Cancer Patients BOCA RATON, Fla., April 24, 2019 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in novel radiation oncology technologies and solutions, today announced that the Company has signed a research and development agreement with the Perelman School of Medicine at the University of […]
Five-Year Retrospective Study Shows 98.9 Percent Cure Rate for Non-Melanoma Skin Cancer Patients Treated with Sensus Healthcare’s Superficial Radio Therapy
Sensus’ SRT-100™ Indicates High Cure Rates in Long-Term Retrospective Study BOCA RATON, Fla., April 23, 2019 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in non-invasive treatments for both oncological and non-oncological conditions, announced today topline results from a five-year retrospective study of non-melanoma skin cancer (NMSC) patients treated with Superficial Radio […]